Skip to content

Medical-device intelligence

NeuMoDx Molecular Inc: FDA clearances and recalls

Research NeuMoDx Molecular Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

2 clearance records and 6 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from Jun 26, 2018 to Dec 22, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
NeuMoDx CT/NG Assay 2.0K230267 · QEPNeumodx Molecular, Inc.510(k)Dec 22, 2023FDA decision date
NeuMoDx Cartridge-used for extraction, purification, amplification and detection of nucleic acids on the NeuMoDx 288 and NeuMoDx 96 Molecular Sys…Z-2255-2023 · PPMNeuMoDx Molecular IncRecallJul 28, 2023FDA classification date
NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal swabs in tra…Z-2093-2023 · QJRNeuMoDx Molecular IncRecallJul 5, 2023FDA classification date
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900Z-1251-2022 · QLTNeuMoDx Molecular IncRecallJun 8, 2022FDA record creation date
NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems with either of the following assays: NeuMoDx SARS CoV-2 Test Strip…Z-1000-2022 · QJRNeuMoDx Molecular IncRecallApr 22, 2022FDA record creation date
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual…Z-0738-2022 · QJRNeuMoDx Molecular IncRecallMar 8, 2022FDA record creation date
NeuMoDx Cartridge, For In Vitro Diagnostic Use on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems, Model Number 100100Z-1978-2021 · QJRNeuMoDx Molecular IncRecallJun 29, 2021FDA record creation date
NeuMoDx GBS AssayK173725 · NJRNeumodx Molecular, Inc.510(k)Jun 26, 2018FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗